9870 Federal Register / Vol. 66, No. 29 / Monday, February 12, 2001 / Notices

Agenda: Program reports and

presentations; Business of the board. For

detailed agenda: See NCI Homepage/

Advisory Board and Groups http://

deainfo.nci.nih.gov/ADVISORY/boards.htm.

Tentative agenda available 10 working days

prior to meetings; Final agenda available 5

working days prior to meetings.

Name of Committee: National Cancer

Advisory Board Subcommittee on Planning

and Budget.

Open: February 13, 12:15 p.m. to 1:20 p.m.

Agenda: To discuss activities related to the

Subcommittee on Planning and Budget.

Contact Person: Cherie Nichols, M.B.A.,

Executive Secretary to the Subcommittee on

Planning and Budget, Director, Office of

Science Policy, National Cancer Institute,

National Institutes of Health, 9000 Rockville

Pike, Building 31, Room 11A03, Bethesda,

MD 20892, (301) 496–5515.

Name of Committee: National Cancer

Advisory Board.

Open: February 13, 1:30 p.m. to 3:45 p.m.

Agenda: Program reports and

presentations; Business of the board. For

detailed agenda: See NCI Homepage/

Advisory Board and Groups http://

deainfo.nci.nih.gov/ADVISORY/boards.htm.

Tentative agenda available 10 working days

prior to meetings; Final agenda available 5

working days prior to meetings.

Closed: February 13, 4 p.m. to Recess.

Agenda: Review of grant applications;

Discussion of confidential personnel issues.

Open: February 14, 8:45 a.m. to

Adjournment.

Agenda: Program reports and

presentations; Business of the board. For

detailed agenda: See NCI Homepage/

Advisory Board and Groups http://

deainfo.nci.nih.gov/ADVISORY/boards.htm.

Tentative agenda available 10 working days

prior to meetings; Final agenda available 5

working days prior to meetings.

Place: National Cancer Institute, Building

31, C Wing, 6th Floor, Conference Room 10,

National Institutes of Health, 9000 Rockville

Pike, Bethesda, MD 20892.

Contact Person: Dr. Marvin R. Kalt,

Executive Secretary, National Cancer

Institute, National Institutes of Health, 6116

Executive Boulevard, 8th Floor, Room 8001,

Bethesda, MD 20892–8327, (301) 496–5147.

This meeting is being published less than

15 days prior to the meeting due to

scheduling conflicts.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support,

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: January 30, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–3464 Filed 2–9–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Center for Complementary &

Alternative Medicine; Notice of Closed

Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Center for

Complementary and Alternative Medicine

Special Emphasis Panel NACCM SEP C–09

R01/R21 Grant Review.

Date: February 26–28, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Four Points by Sheraton Bethesda,

8400 Wisconsin Avenue, Bethesda, MD

20814.

Contact Person: John C. Chah, PhD.,

Scientific Review Administrator, National

Institutes of Health, NCCAM, Building 31,

Room 5B50, 9000 Rockville Pike, Bethesda,

MD 20892, 301–402–4334,

John@mail.nih.gov.

Name of Committee: National Center for

Complementary and Alternative Medicine

Special Emphasis Panel NCCAM–H09 SEP.

Date: February 28–March 1, 2001.

Time: February 28, 2001, 8:30 a.m. to 5

p.m.

Agenda: To review and evaluate grant

applications.

Place: Four Points Sheraton, 8400

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Cecelia Maryland,—Grants

Technical Assistant, National Center for

Complementary and Alternative Medicine,

National Institutes of Health, Building 31,

Room 5B50, Bethesda, Md 20892, (301) 480–

2419.

Name of Committee: National Center for

Complementary and Alternative Medicine

Special Emphasis Panel NCCAM SEP C–08.

Date: March 12–13, 2001.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Four Points by Sheraton Bethesda,

8400 Wisconsin Avenue, Bethesda, MD

20814.

Contact Person: John C. Chah, PhD.,

Scientific Review Administrator, National

Institutes of Health, NCCAM, Building 31,

Room 5B50, 9000 Rockville Pike, Bethesda,

MD 20892, 301–402–4334,

johnc@mail.nih.gov.

Dated: January 30, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–3463 Filed 2–09–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health; National

Eye Institute; Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Eye Institute

Special Emphasis Panel.

Date: March 14, 2001.

Time: 9 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: 6120 Executive Blvd., Suite 350,

Rockville, MD 20892.

Contact Person: Andrew P Mariani, PhD.,

Chief, Scientific Review Branch, 6120

Executive Blvd, Suite 350, Rockville, MD

20892, 301/496–5561.

(Catalogue of Federal Domestic Assistance

Program No. 93.867, Vision Research,

National Institutes of Health, HHS)

Dated: February 1, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–3469 Filed 2–9–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Human Genome Research

Institute; Notice of Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

Federal Register / Vol. 66, No. 29 / Monday, February 12, 2001 / Notices 9871

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications

and/or contract proposals and the

discussions could disclose confidential

trade secrets or commercial property

such as patentable material, and

personal information concerning

individuals associated with the grant

applications and/or contract proposals,

the disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Human

Genome Research Institute Initial Review

Group Genome Research Review Committee.

Date: March 12–13, 2001.

Time: 8:30 a.m. to 6 p.m.

Agenda: To review and evaluate grant

applications and/or proposals.

Place: Bethesda Holiday Inn, 8120

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Ken D. Nakamura, PhD.,

Scientific Review Administrator, Office of

Scientific Review, National Human Genome

Research Institute, National Institutes of

Health, Bethesda, MD 20892, 301 402–0838.

Name of Committee: National Human

Genome Research Institute Initial Review

Group Ethical, Legal, Social Impliations

Review Committee.

Date: March 15, 2001.

Time: 1:30 p.m. to 4 p.m.

Agenda: To review and evaluate grant

applications.

Place: Conference Room B2B32/Bldg 31, 31

Center Drive, Bethesda, MD 20892

(Telephone Conference Call).

Contact Person: Rudy O. Pozzatti, PhD.,

Scientific Review Administrator, Office of

Scientific Review, National Human Genome

Research Institute, National Institutes of

Health, Bethesda, MD 20892, 301 402–0838.

Name of Committee: National Human

Genome Research Institute Initial Review

Group Genome Research Review Committee.

Date: March 28, 2001.

Time: 2 p.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: National Human Genome Research

Institute, National Institutes of Health,

Building 31, Room B2B32, Bethesda, MD

20892 (Telephone Conference Call).

Contact Person: Ken D. Nakamura, PhD.,

Scientific Review Administrator, Office of

Scientific Review, National Human Genome

Research Institute, National Institutes of

Health, Bethesda, MD 20892, 301 402–0838.

(Catalogue of Federal Domestic Assistance

Program No. 93.172, Human Genome

Research, National Institutes of Health, HHS)

Dated: February 2, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–3459 Filed 2–9–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Environmental

Health Sciences; Amended Notice of

Meeting

Notice is hereby given of a change in

the meeting of the National Institute of

Environmental Health Sciences Special

Emphasis Panel, March 19, 2001, 1 p.m.

to March 19, 2001, 3 p.m., NIEHS, 79 T.

Alexander Drive, Building 4401,

Conference Room 3446, Research

Triangle Park, NC, 27709 which was

published in the Federal Register on

January 22, 2001, 66 FR 6641.

The telephone conference call

meeting will be held on February 20,

2001, from 1 p.m. to 3 p.m. at the same

location, instead of March 19, 2000, as

previously advertised. The meeting is

closed to the public.

Dated: January 30, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–3460 Filed 2–9–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of General Medical

Sciences; Notice of Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

General Medical Sciences Special Emphasis

Panel.

Date: March 12–14, 2001.

Time: 8 p.m. to 6 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn Chevy Chase, 5520

Wisconsin Avenue, Chevy Chase, MD 20815.

Contact Person: Richard I. Martinez, PhD.,

Scientific Review Administrator, Office of

Scientific Review, National Institute of

General Medical Sciences, National Institutes

of Health, Natcher Building, Room 1AS–19G,

Bethesda, MD 20892–6200, (301) 594–2849.

Name of Committee: National Institute of

General Medical Sciences Special Emphasis

Panel.

Date: April 22–24, 2001.

Time: 8 p.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn Bethesda, 8120

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Helen R. Sunshine, PhD.,

Chief, Office of Scientific Review, National

Institute of General Medical Sciences, NIH,

Natcher Building, Room 1AS–13, Bethesda,

MD 20892, 301–594–2881.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.375, Minority Biomedical

Research Support; 93.821, Cell Biology and

Biophysics Research; 93.859, Pharmacology,

Physiology, and Biological Chemistry

Research; 93.862, Genetics and

Developmental Biology Research; 93.88,

Minority Access to Research Careers; 93.96,

Special Minority Initiatives, National

Institutes of Health, HHS)

Dated: January 30, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–3461 Filed 2–9–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Mental Health;

Notice of Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applicants and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Mental Health Special Emphasis Panel.

Date: February 21, 2001.

Time: 2 p.m. to 3:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: Neuroscience Center, National

Institutes of Health, 6001 Executive Blvd.,

Bethesda, MD 20892 (Telephone Conference

Call).